Filing step-change
HINDBIO · 2026-09
Quarterly observations that moved versus the prior period in 2026-09. Facts only — not a call to act.
Narrative date 2026-09-30 · Evidence medium
Hindustan Bioengineering (HINDBIO) reported a quarterly gross margin of 41.04%, accelerating from -51.11%.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 41.04 % | -51.11 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -51.11 % | -51.18 | ▲ |
Cite this
Source: Samhati filing step-change for HINDBIO (2026-09). Observation: Hindustan Bioengineering (HINDBIO) reported a quarterly gross margin of 41.04%, accelerating from -51.11%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/hindbio/q/2026-09
Other periods